Skip Navigation
Print Page

Chemical Synthesis Facility

Skip sharing on social media links
Share this:


Scientist pouring chemical in a beakerThe Chemical Synthesis Facility is one of five contracts used by the Contraceptive Discovery and Development Branch (CDDB) (formerly the Contraception and Reproductive Health [CRH] Branch) to support research on the discovery, optimization and development of male and female contraceptive agents.

This facility provides NICHD-supported researchers and other investigators with research grade and clinical grade Active Pharmaceutical Ingredients (APIs).

Topic Areas

The Chemical Synthesis Facility manufactures research grade and clinical grade APIs that are identified as promising agents for male and female contraceptives. The facility can manufacture multikilogram clinical grade API under current Good Manufacturing Practice (cGMP). The research grade APIs are tested in in vitro screening and other studies and in vivo animal studies. The APIs manufactured under cGMP protocol by the facility are used in clinical trials.

More Information

Last Updated Date: 03/23/2015
Last Reviewed Date: 03/17/2015
Vision National Institutes of Health Home BOND National Institues of Health Home Home Storz Lab: Section on Environmental Gene Regulation Home Machner Lab: Unit on Microbial Pathogenesis Home Division of Intramural Population Health Research Home Bonifacino Lab: Section on Intracellular Protein Trafficking Home Lilly Lab: Section on Gamete Development Home Lippincott-Schwartz Lab: Section on Organelle Biology